Ausgabe 11/2006
Inhalt (17 Artikel)
Tumour-expressed tissue factor inhibits cellular cytotoxicity
Chao Li, Lucy M. Colman, Mary E. W. Collier, Charlotte E. Dyer, John Greenman, Camille Ettelaie
Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12
Chang-Hyun Kim, Min-Jung Hong, Sung-Dong Park, Choong-Kwon Kim, Mi-Young Park, Hyun-Jung Sohn, Hyun-Il Cho, Tai-Gyu Kim, Yong-Kil Hong
Expression of macrophage-derived chemokine (MDC)/CCL22 in human lung cancer
Toru Nakanishi, Kazuyoshi Imaizumi, Yoshinori Hasegawa, Tsutomu Kawabe, Naozumi Hashimoto, Masakazu Okamoto, Kaoru Shimokata
Interleukin 2 regulation following semi-allogeneic bone marrow transplantation in mice
Ali Abdul-Hai, Arie Ben-Yehuda, Haya Galsky, Shimon Slavin, Reuven Or
PankoMab: a potent new generation anti-tumour MUC1 antibody
Antje Danielczyk, Renate Stahn, Dorian Faulstich, Anja Löffler, Angela Märten, Uwe Karsten, Steffen Goletz
Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells
Roi Avraham, Shelly Inbar, Ella Rosenne, Shamgar Ben-Eliyahu
Substitution analog peptide derived from HER-2 can efficiently induce HER-2-specific, HLA-A24 restricted CTLs
Kousaku Mimura, Koji Kono, Scott Southwood, John Fikes, Akihiro Takahashi, Naoto Miyagawa, Hidemitsu Sugai, Hideki Fujii
A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells
P. Wolf, D. Gierschner, P. Bühler, U. Wetterauer, U. Elsässer-Beile
Antitumor action and immune activation through cooperation of bee venom secretory phospholipase A2 and phosphatidylinositol-(3,4)-bisphosphate
Thomas Putz, Reinhold Ramoner, Hubert Gander, Andrea Rahm, Georg Bartsch, Martin Thurnher
Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells
Cheryl L.-L. Chiang, Jonathan A. Ledermann, Ariel N. Rad, David R. Katz, Benjamin M. Chain
Immunomodulatory impact of interferon-alpha in combination with chemoradiation of pancreatic adenocarcinoma (CapRI)
Jan Schmidt, Emilia M. Patrut, Jianhua Ma, Dirk Jäger, Hanns-Peter Knaebel, Markus W. Büchler, Angela Märten
International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers
Barbara-ann Guinn, James S. Norris, LaiQiang Huang, Farzin Farzaneh, Noriyuki Kasahara, Albert B. Deisseroth
Targeted and shielded adenovectors for cancer therapy
Susan J. Hedley, Jian Chen, John D. Mountz, Jing Li, David T. Curiel, Nikolay Korokhov, Imre Kovesdi
Virology- and immunology-based gene therapy for cancer
Masatoshi Tagawa, Kiyoko Kawamura, Osamu Shimozato, Guangyu Ma, Quanhai Li, Nobuo Suzuki, Hideaki Shimada, Takenori Ochiai
Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
Jon A. Kyte, Gustav Gaudernack
Non-viral in vivo immune gene therapy of cancer: combined strategies for treatment of systemic disease
M. Tangney, G. Casey, J. O. Larkin, C. G. Collins, D. Soden, J. Cashman, M. C. Whelan, G. C. O’Sullivan